FibroBiologics, Inc. has announced the completion of its proprietary master cell bank, which will support its upcoming clinical trials. Developed in partnership with Charles River Laboratories and ...
SINGAPORE, March 18, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its proprietary ...
REPROCELL (TYO: 4978) today announced the launch of its US FDA compliant Good Manufacturing Practice (GMP) Master Cell Bank (MCB) manufacturing service for human induced pluripotent stem cells (iPSCs) ...
Stem cell banking is now available through every Cenegenics® Medical Institute center for both patients and non-patients, announced the global leader in age management medicine today. Banking ...
Management team: Paula MacDonald, the CEO and co-founder, has more than 25 years’ experience in the biomedical sector. She previously served as CEO of Accugenix. She was also executive director of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results